Skip to main content
. 2019 Nov 13;10:1305. doi: 10.3389/fphar.2019.01305

Figure 2.

Figure 2

Alpha-mangostin (α-MG) reduced the expression of α-smooth muscle actin (α-SMA) and collagen I (Col I) in bleomycin (BLM)-induced PF. One week after BLM treatment (5 mg/kg), mice were intragastrically administered with α-MG (10 mg/kg) or nintedanib (40 mg/kg) once a day for 14 days. Mouse lungs were collected on day 21 after BLM treatment. Protein expression of α-SMA (A) and Col I (B) were detected using Western blot analysis. Relative mRNA expression of α-SMA (C), Col I (D) were detected using real time-PCR analysis. Data were expressed as mean ± SD (n ≥ 3). *p < 0.05, **p < 0.01, ***p < 0.001, NS, non-significant.